Endoscopy Devices Market Scope And Analysis

  • Report Code : TIPHE100000823
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Endoscopy Device Market Scope and Key Players Analysis by 2030

Buy Now

Endoscopy Device Market Report Endoscopy Device Market Size and Share Endoscopy Device Market Scope and Analysis

Endoscopy Device Market Report Scope

Report Attribute Details
Market size in 2022 US$ 30,457.18 Million
Market Size by 2030 US$ 52,100.72 Million
Global CAGR (2022 - 2030) 6.9%
Historical Data 2020-2022
Forecast period 2022-2030
Segments Covered By Product
  • Endoscopes
  • Visualization Systems
  • Accessories
  • Other Endoscopy Devices
By Application
  • Gastroscopy
  • Laparoscopy
  • Arthroscopy
  • Urology Endoscopy
  • Bronchoscopy
  • Laryngoscopy
  • Otoscopy
By End User
  • Hospitals
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Boston Scientific Corp
  • Medtronic Plc
  • Stryker Corp
  • Johnson Johnson
  • Karl Storz SE Co KG
  • Olympus Corp
  • Ambu AS
  • Conmed Corp
  • B Braun SE

    • Industry Developments and Future Opportunities: 

    Various initiatives taken by key players operating in the endoscopy device market are listed below:

    1. In February 2023, Boston Scientific Corp announced that the FDA has approved its LithoVue Elite Single-Use Digital Flexible Ureteroscope System. It is the first ureteroscope system can monitor intrarenal pressure in real-time during ureteroscopy procedures. The LithoVue Elite Single-Use Digital Flexible Ureteroscope System comprises of StoneSmart Connect Console that has upgraded the device to offer upgraded image quality, control features, and streamlined integration.
    2. In September 2023, Ambu expanded its gastroenterology portfolio with the announcement of the Ambu aScope Gastro Large and Ambu aBox 2, two new larger-sized gastroscopy solutions that will be available in Europe. In addition to being the first gastroscope in the world with a 4.2 mm operating channel, which enables gastroenterologists to achieve strong suction performance during procedures in the ICU and endoscopy unit, the Ambu aScope Gastro Large is also the first endoscope ever manufactured of bioplastic materials.
    3. In September 2022, Medtronic plc announced that the US Food and Drug Administration has approved the Nexpowder endoscopic hemostasis system. The hemostasis system is supplied worldwide by Medtronic and is separately developed by NEXTBIOMEDICAL CO., LTD (Korea). Using a catheter with patented powder-coating technology, a noncontact, nonthermal, and nontraumatic hemostatic powder is sprayed to operate the Nexpowder system
    4. In September 2023, Stryker Corp announced the launch of the 1788 platform, which is the next generation of minimally invasive surgical cameras. The camera platform is enhanced with upgraded technology to be used in advanced surgery across multiple specialties. The camera provides a vibrant image with balanced lighting that improves visualization of blood flow and critical anatomy and can visualize multiple optical imaging agents.   

    Competitive Landscape and Key Companies:

    Boston Scientific Corp, Medtronic Plc, Stryker Corp, Johnson & Johnson, Karl Storz SE & Co KG, Olympus Corp, Ambu AS, Conmed Corp, B Braun SE,  and PENTAX Medical are among the prominent companies operating in the endoscopy device market. These companies focus on new technologies, existing products advancements, and geographic expansions to meet the globally growing consumer demand.